Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-21

Clinical Trial Update: JUVÉDERM VOLUX® for Chin Retrusion in China [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updates JUVÉDERM VOLUX for chin retrusion in China has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUVÉDERM VOLUX (volume filler product)

Snippet

Sponsor: Allergan | Conditions: Chin Retrusion | Phase 3 | Status: COMPLETED